About Event
2025 Highlights You Missed:
Interactive Workshop Exploring Cell-Free DNA
Starting the morning with a bang, experts from Pfizer and Beam Therapeutics shared their experience with cell-free DNA.
Comparing DNA quality, stability and immunogenicity, as well as overall timescale, cost and efficiency, this session delved into the challenges and innovations of a cell-free approach.
Attendees brought their curiosity and asked their burning questions on transitioning away from traditional pDNA, and shared the experience they have with cell-free DNA as we unravelled the possibilities and limitations of this exciting approach.
Attendees got firsthand insight from pharma giants Sanofi, AstraZeneca, and Pfizer, who discussed advances in off-the-shelf lysis equipment, advanced purification technologies, and chromatography techniques beyond traditional resin-based approaches.
Attendees quizzed the experts on the latest techniques to bring back to their own downstream process development to streamline their DNA production.
Pharma-led Fireside Chat: Optimizing Downstream DNA Process Development
Refreshed Speaker Faculty & New Expert Companies Attending – Brand new speakers including:
Zsolt Gengeliczki, Associate Director, Analytical Project Lead, Novartis
Mark Geng, Director, Global DS MS&T DNA Lead Moderna
Taesun Eom, Director, RNA Technologies, Chroma Medicine
Jennifer Lin, Director, Preclinical MFG, Beam Therapeutics
James Osborn, Senior Scientist, Preclinical Development, Merck
Brian Korniski, Senior Principal Scientist, Pfizer
Angel Tai, Manager, External QA Operations, Sanofi
Hui Zhi, Principal Scientist, mRNA Process Development, Beam Therapeutics
Suriyasri Subramanian, Senior Scientist, AstraZeneca
Are you looking to meet your fellow Directors, Heads, and Principal Scientists invested in DNA process development, analytical development, regulatory affairs, and CMC?
Join us in 2026 as this niche community of large pharma and innovative biotech gathers over 3 days to assess the emerging technologies in the field, take back actionable insights to your team, and meet the rising demand for DNA production.